Synthesis and binding affinity of 1-(pyrrolidin-1-ylmethyl)-2-(N-methyl)-4-[(3,4-dichloro)phenyl]-1,2,3,4-tetr ahydroisoquinolin-3(2H)-ones

By Pinna G.   Gavini E.   Cignarella G.   Scolastico S.   Fadda P.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 6, 1995-01 ,pp. : 515-520

Elsevier

Access to resources Recommend Favorite

Synthesis and evaluation of cis-1-methyl-3-n-propyl-2,3,3a,4,5,9b-hexahydro-1H-benz[e]indoles for in vitro dopamine D 1 and D 2 receptor binding affinity

By Ghosh D.   Klein C.   Garner B.   Andersen P.   Crider A.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 12, 1995-01 ,pp. : 943-948

Elsevier

Access to resources Recommend Favorite

Topoisomerase I/II selectivity among derivatives of N -[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA)

By Bridewell D.J.A.   Finlay G.J.   Baguley B.C.  

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 317-324

Cognizant Communication Corporation

Access to resources Recommend Favorite

Receptor-binding studies of 1-N-substituted melatonin analogues

By Lira-Rocha A.   Espejo-Gonzalez O.   Naranjo-Rodrguez E.B.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 12, 2002-12 ,pp. : 945-951

Elsevier

Access to resources Recommend Favorite

Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 12, 2015-07 ,pp. : 988-1001

Bentham Science Publishers

Access to resources Recommend Favorite